Oct
25
Wed
Medicine Grand Rounds: Internal Medicine: Addressing Provocative Issues in Today’s Healthcare Environment @ LKSC, Paul Berg Hall
Oct 25 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Internal Medicine: Addressing Provocative Issues in Today’s Healthcare Environment @ LKSC, Paul Berg Hall | Palo Alto | California | United States

Presenter: Steven Weinberger, MD, FACP
Executive Vice President and CEO Emeritus,                                                                                  Associate Executive Vice President, American College of Physicians
Adjunct Professor of Medicine, University of Pennsylvania School of Medicine
Senior Lecturer, Medicine, Harvard Medical School

Steven Weinberger, MD, is Executive Vice President and CEO Emeritus, Associate Executive Vice President, American College of Physicians, Adjunct Professor of Medicine at the University of Pennsylvania, and Senior Lecturer on Medicine at Harvard Medical School. Prior to assuming the role of EVP/CEO in 2010, he served for six years as ACP’s Senior Vice President for Medical Education and Publishing. Before joining the ACP in 2004, Weinberger was on the full-time faculty of Harvard Medical School and Beth Israel Deaconess Medical Center (formerly Beth Israel Hospital) for 26 years. Most recently, he had served simultaneously as Executive Director of the Carl J. Shapiro Institute for Education and Research at Harvard Medical School and Beth Israel Deaconess Medical Center, as Executive Vice Chair of the Department of Medicine at Beth Israel Deaconess Medical Center, and as Professor of Medicine and Faculty Associate Dean for Medical Education at Harvard Medical School.

Nov
1
Wed
Medicine Grand Rounds: Top 6 Myths about Back Pain and Spine Issues @ LKSC, Berg Hall
Nov 1 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Top 6 Myths about Back Pain and Spine Issues @ LKSC, Berg Hall | Palo Alto | California | United States

Presenter: Joshua Levin, MD
Clinical Assistant Professor, Orthopaedic Surgery
Stanford University

Joshua Levin, MD, completed a residency in physical medicine and rehabilitation at the University of Michigan in 2007, and a pain medicine fellowship at the Virginia Commonwealth University in 2008. Currently, he is a member of both the departments of orthopedic surgery and neurosurgery at Stanford University, where he also is the director of the PM&R interventional spine fellowship.

Nov
8
Wed
Medicine Grand Rounds: Features and Outcomes of Methampehtamine Associated Pulmonary Arterial Hypertension @ LKSC, Berg Hall
Nov 8 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Features and Outcomes of Methampehtamine Associated Pulmonary Arterial Hypertension @ LKSC, Berg Hall | Palo Alto | California | United States

Presenters: Vinicio A. de Jesus Perez, MD and Roham Zamanian, MD
Perez: Assistant Professor of Medicine, Pulmonary and Critical Care
Zamanian: Associate Professor of Medicine, Pulmonary and Critical Care                                 Stanford University

Perez received his MD from the University of Puerto Rico Medical School and completed an internal medicine residency at Massachusetts General Hospital. He completed a fellowship in pulmonary and critical care medicine in Denver, followed by postdoctoral research training at Stanford University. He focused on researching genetic and molecular mechanisms of pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF) and has devoted his clinical practice to diagnosis and management of these conditions. He is presently assistant professor of medicine and staff physician of the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF.

As a medical professional belonging to a minority group, Dr. de Jesus Perez is involved in academic endeavors seeking to improve access of care for patients with disadvantageous ethnic backgrounds and promote diversity in medicine.

Zamanian specializes in the treatment of pulmonary hypertension, right heart failure, and pulmonary embolism. He has more than 13 years of sub-specialty experience in pulmonary vascular diseases. Dr. Zamanian is considered one of the leading national experts in clinical trials and drug development for pulmonary hypertension.